Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01106404 · ClinicalTrials.gov registry record · NA
RestoreSensor Study
A NA study of Chronic Pain, sponsored by MedtronicNeuro.
- Completed
- Registry status
- NA
- Development phase
- 79
- Enrollment target
- 10
- Study locations
NCT01106404: Completed NA study of Chronic Pain, sponsored by MedtronicNeuro.
NCT01106404 is a NA study of Chronic Pain that has completed, run by MedtronicNeuro. The registered enrollment target is 79 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (90% lower). The trial reports 10 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01106404, a NA study of Chronic Pain, has completed, sponsored by MedtronicNeuro.
- COMPLETED
- Registry status
- NA
- Development phase
- 79 participants
- Enrollment target
- 10
- Study locations
Study Summary
The purpose of the study is to gather clinical information on subjects' experiences with and without the use of the new feature of the RestoreSensor implantable neurostimulator (INS).
Primary Outcome
After subjects experienced both AdaptiveStim and manual programming at 16 weeks post-implant, subjects were asked to compare pain relief and convenience when they had AdaptiveStim ON to AdaptiveStim OFF in two separate domains using two 5-point Likert scales. The outcome measure for the primary objective is the percentage of subjects who report improved pain relief with no loss of convenience or improved convenience with no loss of pain relief during the AdaptiveStim programming arm relative to
Conditions Studied
Interventions
- DEVICE RestoreSensor Neurostimulation System
Study Locations (10)
Texas
- - Dallas
- - San Antonio
- - San Antonio
Alabama
- - Huntsville
California
- - Oceanside
Minnesota
- - Edina
Nevada
- - Las Vegas
New Jersey
- - Voorhees Township
Oregon
- - Eugene
Utah
- - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2010-04 |
| Est. Completion | 2011-01 |
| Phase | NA |
What the finished NCT01106404 record still lists
NCT01106404 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 79 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which RestoreSensor Neurostimulation System is the first listed.
NCT01106404 lists 10 locations in 8 states (Texas, Alabama, California).
Frequently Asked Questions
What is clinical trial NCT01106404 about?
NCT01106404 is a clinical study titled "RestoreSensor Study". The purpose of the study is to gather clinical information on subjects' experiences with and without the use of the new feature of the RestoreSensor implantable neurostimulator (INS).
What is the current status of trial NCT01106404?
This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2010-04. Estimated completion is 2011-01.
What conditions does trial NCT01106404 study?
This clinical trial studies the following conditions: Chronic Pain.
What interventions are being tested in trial NCT01106404?
The interventions under investigation include: RestoreSensor Neurostimulation System (DEVICE).
Who is sponsoring clinical trial NCT01106404?
This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01106404 being conducted?
This trial has 10 study locations across Alabama, California, Minnesota, Nevada, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01106404's enrollment target sits among peer trials
79 155th of 301 higher than 147 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05798897 · 79 participants · Phase 1
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- NCT06042439 · 79 participants · NA
AM vs PM Exercise Training
- NCT06223555 · 79 participants · NA
Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia